| PACKAGING TYPE: | 10x10 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Repaglinide (1mg) + Voglibose (0.2mg) |
| FORMULATION: | Tablet |
| Description: | Repamade V102 Tablet is a fixed-dose combination medication developed by Agrosaf Pharmaceuticals to effectively manage type 2 diabetes mellitus. Each tablet contains: Repaglinide (1 mg): A meglitinide that stimulates the pancreas to release more insulin after meals, helping to control postprandial blood sugar spikes. Voglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestines, leading to a slower rise in blood sugar levels after meals. |
| Side Effects: | Hypoglycemia (low blood sugar levels) Flatulence Diarrhea |
| Product Benefits: | Effective Postprandial Blood Sugar Control: Combines two mechanisms to reduce post-meal blood sugar spikes. Reduces Risk of Diabetes-Related Complications: Helps prevent long-term complications such as kidney damage, nerve damage, and eye problems. Conv |










